Truist Financial Maintains Argenx SE(ARGX.US) With Buy Rating
Truist Financial Maintains Argenx SE(ARGX.US) With Buy Rating
Truist Financial Issues a Buy Rating on Argenx Se (ARGX)
Evercore ISI Raises Price Target on Argenx to $555 From $533, Keeps Outperform Rating
JP Morgan Maintains Overweight on Argenx, Raises Price Target to $640
Argenx Analyst Ratings
J.P. Morgan Maintains Argenx SE(ARGX.US) With Buy Rating, Raises Target Price to $640
Argenx Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX), IGC Pharma (IGC) and Fresenius Medical Care AG & Co. KGaA (GB:0H9X)
Baird Adjusts Price Target on Argenx to $515 From $490, Maintains Outperform Rating
Jefferies Maintains Argenx SE(ARGX.US) With Buy Rating, Maintains Target Price $598
Baird Maintains Argenx SE(ARGX.US) With Buy Rating, Raises Target Price to $515
Truist Financial Maintains Argenx SE(ARGX.US) With Buy Rating
Truist Financial Keeps Their Buy Rating on Argenx Se (ARGX)
Baird Maintains Outperform on Argenx, Raises Price Target to $515
Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX) and Boston Scientific (BSX)
A Quick Look at Today's Ratings for Argenx SE(ARGX.US), With a Forecast Between $533 to $585
Wedbush Maintains Outperform on Argenx, Raises Price Target to $560
Argenx Price Target Raised to $547.00/Share From $543.00 by Wells Fargo
A Quick Look at Today's Ratings for Argenx SE(ARGX.US), With a Forecast Between $497 to $598